AC-P19M
AC-P19M is an anticancer peptide. AC-P19M induces apoptosis by disrupting the cell membrane of cancer cells. AC-P19M reverses epithelial-mesenchymal transition (EMT). AC-P19M shows anti-angiogenic activity through the inhibition of VEGF-VEGFR2/ERK/Akt signaling. AC-P19M can be used for lung cancer research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C102H186N26O20
- Peso molecular:2096.73
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas VEGFR
MoreVer todos los productos específicos de isoformas Caspase
More
Actividad biológica
AC-P19M (0.1-100 μM, 24 h) shows potent anticancer activity against lung cancer cells (A549 and H460), while showing low toxicity towards normal (BEAS-2B) and red blood cells[1].
AC-P19M (0.1-100 μM, 6 h) induces lactate dehydrogenase (LDH) release in A549 and H460 cells, indicating that it disrupts cell membranes, leading to cell death[1].
AC-P19M (2-10 μM, 24 h) induces cell apoptosis in A549 and H460 cells through the Bcl-2/Bax/caspase 3 cascade[1].
AC-P19M (0.2-0.5 μM, 24 h) inhibits the migration and invasion of A549 and H460 cells by reversing mesenchymal properties and the expression of EMT markers, ultimately inhibiting EMT process[1].
AC-P19M (10 μM, 12 h) exhibits an anti-angiogenic effect by contributing to the reduction of tubular morphology in human umbilical vein endothelial cells (HUVECs), while inhibiting VEGF-VEGFR2/ERK/Akt signaling[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549 and H460 cells
-
Concentration:0.2, 0.5, 2, 5, and 10 μM
-
Incubation Time:24 h
-
Result:Significantly decreased Bcl-2 levels, showing almost no expression at 10 μM.
Upregulated Bax protein levels to 2.5-fold in a concentration-dependent manner.
Resulted in a more than 2-fold increase of caspase 3.
Increased the expression levels of E-cadherin, while decreased the expression levels of N-cadherin and vimentin.
-
Cell Line:A549 and H460 cells
-
Concentration:0.2 and 0.5 μM
-
Incubation Time:24 h
-
Result:Inhibited cell migration by more than 20% in both A549 and H460 cells.
-
Cell Line:A549 and H460 cells
-
Concentration:0.2 and 0.5 μM
-
Incubation Time:24 h
-
Result:Inhibited cell invasion by more than 20% in both A549 and H460 cells.
Chemical Information
-
Peso molecular 2096.73
-
Fòrmula C102H186N26O20
-
Sequence
Phe-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Lys-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Leu-Ala-Leu
-
Sequence Shortening
FAKKLAKLKKKLAKLALA
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
AC-P19M Related Classifications
HY-P11198 Related Classifications
Powered by Bioz